A hand preparing to type on a laptop.
October 21, 2021

Everything You Need To Know About PBM Rebate Transparency

Looking Behind the PBM Curtain

If there’s one thing on which state and federal governments agree is skyrocketing prescription drug prices. Across the U.S., 109 PBM bills are pending in state legislatures, with 44 pending specifically on transparency, according to the National Academy for State Health Policy.

In the U.S. Congress, the Pharmacy Benefit Manager Accountability Study Act of 2021 was introduced by Senator Marsha Blackburn of Tennessee on February 2, 2021. And this is on the heels of two other bills introduced in 2019—The Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act and the Payment Commission Data Act—neither of which has yet to be signed into law. All of these bills address PBM rebate transparency.

Beyond these attempts at legislating transparency, the U.S. Departments of Health and Human Services, Labor, and Treasury issued the final Transparency in Coverage rule on October 29, 2020, increasing the necessary transparency on health care pricing, making these prices available to consumers.

More significantly, on December 27, 2020, the Consolidated Appropriations Act (CAA) of 2021 was signed into law, requiring the most sweeping changes for employee benefit plans since the Affordable Care Act (ACA). In addition, the CAA includes numerous provisions on health plan transparency around pricing and costs.

Transparency is clearly a hot topic of conversation legislatively. And, although most PBMs prioritize transparency in their business models, the complexity of the marketplace often makes achieving transparency an arduous process, almost impossible to truly achieve.

What is PBM Transparency?

But what does PBM transparency mean? And how does transparency relate to rates, negotiating power, and disclosures?

Read on to learn more about PBM rebate transparency in today’s market.

Everything You Thought You Knew About PBM Rebates

As a recap, entering the healthcare market in the 1960s, PBMs are now functioning “at the center of the pharmaceutical supply chain, acting as intermediaries between insurers, drug manufacturers, and pharmacies.” These integral entities are responsible for negotiating two-thirds of the six billion prescriptions filled annually in the U.S. alone for health plans.

As a service to health plans, PBMs negotiate prescription discounts and rebates on their behalf, creating savings at the plan level for employees and their families. Thus, PBMs are involved in determining how much employers and employees pay for their prescriptions at the pharmacy.

How do PBMs get compensated for their services?

Like many plan service providers, they generate revenue through service and administrative fees. However, they also generate revenue through drug manufacturer rebates.

According to the University of Southern California’s Leonard D. Schaeffer Center for Health Policy and Economics,

List prices are set by drug manufacturers and don’t reflect rebates paid and discounts given, which reduce the net price the manufacturer ultimately receives for the sale of its drugs. Rebates are money refunded to the PBM from the manufacturer, often in exchange for giving their drug preferred formulary placement. Understanding the relationships between list prices and rebates is important because it informs the degree to which policymaker efforts to lower drug prices should target manufacturers or other players in the system, specifically PBMs.

Because of these rebates, however, PBMs can pass along significant savings to their health plan clients. However, it’s these rebates that have become controversial.

According to the Common Wealth Fund, “manufacturing rebates to PBMs increased from $39.7 billion in 2012 to $89.5 billion in 2016, partially offsetting list price increases.” Many believe – and many PBMs state – that they’re passing these savings to their health plan clients. A recent study found that “the share of rebates PBMs passed through to insurers and payers increased from 78 percent in 2012 to 91 percent in 2016.”

Whether some or all savings are “passed-through” is part of the ongoing controversy. This also serves as one of the three primary rebate pricing models that PBMs adopt.

Let’s look at each one in-depth.

Common PBM Rebate Pricing Models

The government, employers, health plans, and patients demand more transparency in drug pricing and rebates. And it’s not just PBM rebate transparency with which these entities are concerned. It’s also achieving lower health plan costs, especially including pharmaceuticals.

For PBMs to continue positively contributing to these conversations, they’ll need to examine their rebate pricing models. Today, the three standard models include the traditional, pass-through, and hybrid models.

Traditional Model

The traditional pricing model occurs where the PBM charges the plan sponsor a set, contracted price for the drugs (with specific discounts) but pays the pharmacy a different rate. The difference between the two prices (often called the “spread”) is what the PBM retains as part of its compensation.

In this traditional model, PBMs negotiate both rebates and discounts, helping the plan sponsor achieve cost savings. However, as part of their compensation, they often retain a percentage of any available rebates and discounts. Unlike the pass-through model, discussed next, PBMs don’t pass all rebates and discounts to the plan sponsor.

Pass-Through Model

The pass-through model is essentially the opposite of the traditional model, often referred to as the most transparent (although those utilizing the traditional model may disagree). The PBM passes 100% of all rebates and discounts to the plan sponsor in this rebate model, retaining none. In this model, compensation is based on administrative fees per transaction or member, not rebates. Thus, the plan sponsor (and their employees) receive the full benefit of any negotiated rebates while the PBM’s business practices are visible.

Hybrid Model

The hybrid model – you guessed it – is a rebate model that combines traditional and pass-through models. To provide some insight into business practices, PBMs may share rebates fully with plan sponsors on specific prescriptions where, on others, they employ a spread compensation structure. In addition, hybrids may or may not charge administrative fees.

How Do PBMs Continue to Achieve Transparency?

Exploring and understanding a PBM’s approach to transparency is essential. It not only helps to align interests in pharmaceutical cost control, but it also encourages greater transparency across all supply chain channels, such as drug manufacturers and healthcare providers.

By Understanding the PBM Contract

Understanding the PBM’s business model is one way to get a glimpse of transparency, as well as knowing what’s in the PBM contract is equally important. According to the Pharmaceutical Care Management Association, PBMs can further demonstrate their active transparency by “[p]roving information to clients on all contract terms, including how PBMs are paid for their services and negotiated rebates.”

By Identifying the Right Tools

Another way to explore PBM rebate transparency is through the tools they use to identify prescription costs and drug utilization. With the right tools, such as real-time data analysis and automated reporting, PBMs can continue to showcase transparency, helping employers, providers, consumers and even governmental agencies to make more “informed decisions that lead to optimal health outcomes.”

Find out how Xevant's turnkey platform allowed a client to send real-time reports

Attaining Greater PBM Performance and Transparency

Once transparency is achieved with the appropriate tools, both PBMs and plan sponsors can achieve greater performance at a lower net cost. By aligning the PBM’s financial interests with those of the plan sponsor, employers can better manage their drug costs by basing coverage on the lowest net costs as opposed to higher rebates.

Clearly, transparency extends beyond just the PBM’s business model type. As transparency continues to dominate healthcare conversations, PBMs will need to continue to emphasize their approach to transparency, differentiating themselves from the competition while lining their services up against the plan sponsor’s desire for increased utilization and cost control.

To help curb healthcare costs and increase transparency, ensure you have detailed, actionable data to help your plan sponsor clients manage their pharmacy spend. Whether you’re a PBM, TPA, or benefits manager, Xevant provides the data you need before you need it.

Return To Blog
Brandon Newman, CEO of Xevant


Brandon Newman, CEO of Xevant

"Brandon has a dynamic, 25-year leadership career spearheading several businesses with emphasis on growth, revenue, and sales performance. He has run many high-growth environments, including start-ups, turnarounds, and $1B+ dollar businesses. As a serial entrepreneur, he has a proven record of founding new businesses and advancing them through growth and acquisition, merger, or roll-up including ScripPoint, Veridian, and AviaraMD. He is the driving force for vision, new market strategy, revenue growth, technology development, and partner alliances."


Xevant logo with stylized X.

Blog Sign up

Subscribe to our blog and receive the latest Xevant news and updates.

This field is for validation purposes and should be left unchanged.

Mitch Searle

Director, Demand Marketing

Mitchell is a seasoned marketing leader with over a decade of experience driving direct-response demand. From bootstrap budgets to multi-million dollar per month budgets, Mitchell knows how to ensure positive returns on marketing investments. With extensive experience in both B2C and B2B, he has a knack for delivering show-stopping and world-class campaigns that generate immediate impact as well as long-lasting impressions.

Dave Sanders headshot (640x462)

Dave Sanders

VP, Data

With almost 20 years of experience as a senior executive and strategic leader in the data industry, Dave transforms companies through innovative technology solutions. He’s built high performing teams at various types of companies, including Ancestry, the New England Patriots, and Vivint. Dave has successfully migrated many companies to the cloud and always enjoys the challenge of improving processes. He’s excited to help lead Xevant data engineering to make an impact in healthcare.

David Ninow

VP, Product Management

Serving as Xevant’s VP of Product Management, David is a product and technology executive who has led and scaled successful product teams at organizations ranging from high-growth startups to established multi-billion-dollar B2B brands. With expertise building innovative SaaS solutions that disrupt established markets, he is laser-focused on driving the realization of Xevant’s industry-changing vision with world-class product strategy and execution. David is an avid outdoorsman, musician, and family man; perfectly positioned at the foot of the beautiful Wasatch Mountains in Utah.

Key Insights to Stay Ahead of the Curve

From the 2023 drug trend report

Pete Tantillo

Pete Tantillo

Chief Financial Officer

Pete is an accomplished technology executive who has led many organizations through high growth and profitability stages and has worked with some of the world’s largest companies. Pete most recently completed an exit for RapidRatings, a highly successful data and information analytics company in the risk management and supply chain analytics space where he was both CFO and COO for the business. Prior to RapidRatings, Pete spent ten years working for private-equity and venture backed technology companies in both SaaS and traditional software solutions. Pete also spent 13 years at powerhouse technology company SAP where he led field services for SAP America. Pete started his career in public accounting with Arthur Andersen & Co and is a licensed CPA. He graduated with a business degree from the College of William & Mary in Virginia. 

Ashwin Patel

SVP, Data

Ashwin (Ash) has more than 20 years leadership experience in data warehousing and business intelligence practices within the healthcare sector. At Xevant, Ash leads the data and business intelligence teams and is responsible for future state expansion of Xevant data technology platforms and processes, partnering with the organization’s product teams to develop best-in-class products and solutions. Prior to Xevant, Ash was VP Business Intelligence for HealthSmart Benefit Solutions based in Irving, TX, a third-party administrator (TPA) of medical, pharmacy, and clinical data. Ash earned a Bachelor of Science degree in computer science and operations research from Leeds Becketts University in Leeds, England.

Sahily Paoline

Chief Clinical Officer

Sahily is a licensed pharmacist and expert business leader with more than 20 years of experience delivering high-quality clinical care, building and leading organizations, and staffing and motivating teams in the pharmaceutical and digital health industries. Sahily specializes in Clinical Program Management, Pharmacy Practice and Operations, and building and growing business. She is passionate about the use of data and technology in patient care and believes in a holistic approach to healthcare.
Megan Foster headshot

Megan Foster

Manager, People Operations

Todd Rode

VP, Services & Corporate Operations

Todd served as an Artillery officer in the U.S. Army before a disability turned his focus to the business world. He’s carried a bag, led multiple sales operations and sales development efforts, and run a sales team in complex selling environments. The son of small business owners, Todd enjoys helping business leaders grow by using proven, repeatable processes. He holds a BS from the United States Military Academy at West Point and an MBA from the Kellogg School of Management at Northwestern University. Todd lives in Nashville with his wife. He spends as much time outside as possible and co-founded a brewery in 2019.  He’d love to tell you the full story over a pint sometime.

Marvin Roi Elvambuena headshot

Marvin Roi Elvambuena

Director, Web Development

Marvin is responsible for all aspects of software development efforts at Xevant, including architecting and managing software solutions from the ground up. He brings with him a performance history of leading loosely defined enterprise software projects in rapid changing environments. He has previously worked in several industries such as HR solutions, insurance, shared services, and payroll and holds a BS in Information Technology with specialization in Web Development.

Jaylyn Palmer headshot

Jaylyn Palmer

Chief of Staff

Jaylyn is a dynamic Chief of Staff who thrives on helping create workplaces that go beyond the ordinary to achieve a culture of belonging, empowerment, and improvement. Proving to be a culture ambassador, strategic advisor, and relationship builder, Jaylyn supports the organization with versatility and innovation. When she’s not wearing one of her many Xevant hats, you can find Jaylyn planning a party, attending live music and theater, or playing Dungeons and Dragons.

Scott Sorenson

Chief Technology Officer

Scott is an expert business leader with extensive experience scaling technology organizations. His experience includes technology leadership roles at Cedar Health Payment Solutions, Human Longevity, Inc., and 16 years at Ancestry where he was the Chief Technology Officer and played an integral role scaling the Ancestry family history business that hosts billions of historical records and serves millions of customers. He also led their technology organization as they transformed the business to include a world class consumer genomics product line. At Ancestry, Scott prepared the technology organization for an IPO and multiple PE transactions.
Greg Abram headshot

Greg Abram

Chief Growth Officer

Greg is a results-driven sales professional with more than 12 years of experience in the PBM and healthcare markets. As VP of Sales, Greg leads the Xevant sales team focused on growing revenue and expanding market reach. Prior to Xevant, Greg served in multiple leadership and growth positions with Myriad Genetics, Navitus Health Solutions, Catamaran, and CVS Caremark Corporation. Greg’s passion to create long-lasting, aligned partnerships has delivered tremendous value for PBMs, health plans, large purchasing groups, and fortune 500 organizations throughout the country.
Jeff Weber headshot

Jeff Weber

Chief Operating Officer

Jeff has extensive experience building and growing positive organizational culture that supports high performance, transparency, learning and growth. Jeff has implemented comprehensive talent strategy including talent acquisition, engagement, rewards, and recognition programs. Prior to Xevant, Jeff was the EVP People and Places at Instructure, a rapidly growing provider of the Canvas and Bridge learning management platforms focused on transforming online learning and employee development.Jeff also led the growth of the people function for Jeff holds an MBA with an emphasis in Organizational Behavior from Brigham Young University.
Griff McGee headshot

Griff McGee

Corporate Controller

Griffin is CPA and finance and accounting professional with more than 10 years’ experience in public accounting, internal audit, and consulting. Throughout his career Griffin has worked with clients to solve complex problems, improve and implement new processes and achieve public company readiness. Prior to joining Xevant, Griffin served in several audit and consulting roles with Protiviti, Change Healthcare, Genesco and Decosimo, CPAs.

Daniel Telford

Director, Corporate Treasurer

Daniel is a financial professional with more than 15 years of financial and management experience. Having worked in multiple demanding roles including Business Banker, Licensed Investment Professional and Financial Center Manager, Daniel uses his experience to guide and inform his current role as Corporate Treasurer for Xevant. Daniel has led multiple complex cross-functional teams to sustained success in the financial services industry.

Gerrit Lemmen headshot

Gerrit Lemmen

VP, Rebates

Gerrit is an experienced leader in the PBM, Specialty and Formulary rebate markets. As VP of Rebates at Xevant, Gerrit is responsible for managing drug rebates through Xevant’s revolutionary pharmacy benefits platform. In his previous roles at Magellan Rx Management, Gerrit led highly respected commercial rebate operations teams and focused on increasing efficiency that enabled scalability and growth.

Mike Simmons headshot

Mike Simmons

VP, Product Management

Mike is a true product champion & ambassador with 18+ years of experience in critical product launch, strategic branding, and delivering profitable campaigns that capture market share and create growth. His vision and skills for implementing integrated, high-impact, go-to-market strategies have proven to drive increased sales and an overall improvement of marketing programs. Mike’s ability to leverage business savvy in order to align management, data intelligence, and content management generate more informed business decisions resulting in enhanced revenue for progressive, enterprise organizations.

Laura Phillipson

VP, Strategic Accounts

Laura Phillipson is a client management expert with experience managing client services teams. Her past roles include Sr. Client Services Executive for Navitus and over a decade of experience as a Certified Pharmacy Technician. Laura’s career in client relations spans nearly two decades. An avid sports fan, Laura excels in helping clients create a strong strategy with a competitive edge. Laura’s extensive background in both customer service and the medical field provides an ideal blend to lead client management for Xevant.

Chad Davis headshot

Chad Davis

Director, Compliance

Chad is a credentialed and strategic audit and compliance professional with more than 10 years’ experience assisting companies with achieving their business objectives through adept governance, compliance, and risk management. Prior to Xevant, Chad served in several auditing and accountant roles for Protiviti, Intermountain Healthcare, and First Data Corporation. He is a credentialed CISM and CISA and holds a BS in Accounting.

Erin Glenn

Director, Data Warehouse

Erin is 20-year data warehousing and business intelligence technology leader who has conceptualized, designed, and implemented ground-breaking data-centric technology solutions. She has solved big problems, delivered operational efficiencies, and increased productivity and cost savings throughout her career by delivering enterprise class data warehouses and business intelligence solutions.  Prior to Xevant, Erin served in multiple technology leadership positions with Hampton Roads Transit, MSN, The Port of Virginia, and Innova Systems. She holds a bachelor’s degree from the University of Hawaii.

Greg Heaps

Chief Marketing Officer

Greg is an expert marketer and innovative business builder specializing in launching and building high growth companies. As a founding member and on the leadership team of multiple venture backed tech startups, Greg has extensive experience in numerous markets including software services, health and medicine, commercial real estate, and consumer focused products. His primary motivation is driving demand and growth through an omni channel, go-to-market strategy. When Greg is not neck deep building an exhilarating business, he can often be found mountain biking, fly fishing, or carving deep powder on remote mountains.

Headshot of Jace Garfield, the Chief Technology Officer.

Jace Garfield

Chief Analytics Officer

Jason (Jace) Garfield, MSW has thrived in many industries ranging from data and information technology to foster care and mental health management. In his role with the Utah State Justice Commission, he helped publish medical research on drug effectiveness. Jason’s passion for technology and data automation paved the way towards innovations in identifying new to market drugs, tracking systems to identify clinical interventions, and data automations, resulting in millions in operational cost reductions. At Xevant, Jace leads every aspect of product operations and is responsible for a diverse team of technology experts.

Jason Hardin headshot

Jason Hardin

Chief Revenue Officer

With 20+ years of sales and sales management experience in SaaS sales and professional services, Jason is a dynamic, performance driven leader with an exceptional record of achievement in motivating sales teams to exceed quotas, while ensuring client success.  Having led many organizations in the start-up, high growth, and emerging phases, Jason brings an entrepreneurial hunger to the sales, client success, and business development organizations with the ability to penetrate new markets, produce high growth sales results, achieve adoption and retention goals, and grow market share and revenue quickly.  

Jeff Lininger

President & COO

Jeff is the Chief Operating Officer at Xevant and is accountable for operational excellence at the company. Prior to joining Xevant, Jeff successfully applied his extensive, multidisciplinary expertise in building and scaling growth and service infrastructures within start-up, mid-market, and Fortune 500 technology and services companies. He has recruited and built new leadership and functional teams within operations, sales, marketing, product development, client success, finance, and HR. The success of these business transformations also contributed to a culture of increased accountability and empowerment, contributing to significant improvement in employee engagement and overall enhanced business performance. Jeff holds an MBA from Duke University’s Fuqua School of Business in North Carolina and a Bachelor’s Degree in Finance and Economics from Grove City College in Pennsylvania.

Headshot of Lindsay Jones, the Chief Financial Officer.

Lindsay Jones

Chief Financial Officer

Lindsay Jones, CPA, is a financial executive with experience in start-up companies & mature enterprises. He has a proven track record of helping, leading, and enhancing executive management teams. He has worked with private equity groups and private investors to identify, analyze, and close acquisitions and divestitures of companies. He has founded two startup companies, owned his own business, and closed over $500 million in private and public equity and debt financing, in his twenty-year career. 

Brandon Newman

Chief Executive Officer

Brandon has a dynamic, 25-year leadership career spearheading several businesses with emphasis on growth, revenue, and sales performance. He has run many high-growth environments, including start-ups, turnarounds, and $1B+ dollar businesses. As a serial entrepreneur, he has a proven record of founding new businesses and advancing them through growth and acquisition, merger, or roll-up including ScripPoint, Veridian, and AviaraMD. He is the driving force for vision, new market strategy, revenue growth, technology development, and partner alliances.